{"id":"https://openalex.org/W2102408640","doi":"https://doi.org/10.5694/j.1326-5377.2003.tb05417.x","title":"A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial","display_name":"A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial","alternate_titles":[],"publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W2102408640","doi":"https://doi.org/10.5694/j.1326-5377.2003.tb05417.x","mag":"2102408640","pmid":"https://pubmed.ncbi.nlm.nih.gov/12831383"},"language":"en","primary_location":{"id":"doi:10.5694/j.1326-5377.2003.tb05417.x","doi":"https://doi.org/10.5694/j.1326-5377.2003.tb05417.x","is_oa":false,"landing_page_url":"https://doi.org/10.5694/j.1326-5377.2003.tb05417.x","pdf_url":null,"source":{"id":"https://openalex.org/S13978405","display_name":"The Medical Journal of Australia","issn_l":"0025-729X","issn":["0025-729X","1326-5377"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Australia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2102408640"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109396258","display_name":"Amy Gibson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405258728","display_name":"National Drug and Alcohol Research Centre","ror":"https://ror.org/0144fat78","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy E Gibson","raw_affiliation_strings":["National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031345113","display_name":"Christopher M. Doran","orcid":"https://orcid.org/0000-0002-9009-4906","observed_orcids":["https://orcid.org/0000-0002-9009-4906"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405258728","display_name":"National Drug and Alcohol Research Centre","ror":"https://ror.org/0144fat78","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher M Doran","raw_affiliation_strings":["National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102716596","display_name":"James R Bell","orcid":"https://orcid.org/0000-0002-5117-0216","observed_orcids":["https://orcid.org/0000-0002-5117-0216"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4405258728","display_name":"National Drug and Alcohol Research Centre","ror":"https://ror.org/0144fat78","country_code":"AU","type":"facility","lineage":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James R Bell","raw_affiliation_strings":["National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4405258728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002765940","display_name":"Anni Ryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802601309","display_name":"Sydney Hospital","ror":"https://ror.org/0402tt118","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802601309","https://openalex.org/I4210147382"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anni Ryan","raw_affiliation_strings":["The Langton Centre, Sydney Hospital and Sydney Eye Hospital, Sydney, NSW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Langton Centre, Sydney Hospital and Sydney Eye Hospital, Sydney, NSW","institution_ids":["https://openalex.org/I2802601309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076740440","display_name":"Nicholas Lintzeris","orcid":"https://orcid.org/0000-0001-5229-8257","observed_orcids":["https://orcid.org/0000-0001-5229-8257"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicholas Lintzeris","raw_affiliation_strings":["National Addiction Centre, Institute of Psychiatry, Kings College, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Addiction Centre, Institute of Psychiatry, Kings College, London, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3400,"currency":"USD","value_usd":3400},"apc_paid":null,"fwci":11.4296,"has_fulltext":false,"cited_by_count":102,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9867533,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"179","issue":"1","first_page":"38","last_page":"42"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.8370000123977661},{"id":"https://openalex.org/keywords/opioid-detoxification","display_name":"opioid detoxification","score":0.8339999914169312},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.8619999885559082},{"id":"https://openalex.org/keywords/specialty-clinics","display_name":"specialist clinics","score":0.5519999861717224},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.7889999747276306},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9570000171661377},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.7789999842643738},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.7419999837875366},{"id":"https://openalex.org/keywords/opioid-use","display_name":"opioid use","score":0.46299999952316284},{"id":"https://openalex.org/keywords/general-practice","display_name":"general practice","score":0.44999998807907104},{"id":"https://openalex.org/keywords/drug-treatment-services","display_name":"drug treatment services","score":0.42899999022483826},{"id":"https://openalex.org/keywords/australia","display_name":"Australia","score":0.34599998593330383},{"id":"https://openalex.org/keywords/new-south-wales","display_name":"New South Wales","score":0.5419999957084656},{"id":"https://openalex.org/keywords/united-kingdom","display_name":"United Kingdom","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8484408855438232},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8236614465713501},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.7100138664245605},{"id":"https://openalex.org/C2780497538","wikidata":"https://www.wikidata.org/wiki/Q1192006","display_name":"Detoxification (alternative medicine)","level":3,"score":0.7046323418617249},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.6734639406204224},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.656665563583374},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5053310990333557},{"id":"https://openalex.org/C2984752397","wikidata":"https://www.wikidata.org/wiki/Q3259956","display_name":"Primary care","level":2,"score":0.461859792470932},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.4189954400062561},{"id":"https://openalex.org/C79736992","wikidata":"https://www.wikidata.org/wiki/Q7316676","display_name":"Retention rate","level":2,"score":0.413848876953125},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3855951428413391},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2749878764152527},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2691441774368286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21588701009750366},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.20210155844688416},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.14273911714553833},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.13033685088157654},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000554","descriptor_name":"Ambulatory Care Facilities","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000554","descriptor_name":"Ambulatory Care Facilities","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005194","descriptor_name":"Family Practice","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005194","descriptor_name":"Family Practice","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009517","descriptor_name":"New South Wales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010043","descriptor_name":"Outcome and Process Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5694/j.1326-5377.2003.tb05417.x","doi":"https://doi.org/10.5694/j.1326-5377.2003.tb05417.x","is_oa":false,"landing_page_url":"https://doi.org/10.5694/j.1326-5377.2003.tb05417.x","pdf_url":null,"source":{"id":"https://openalex.org/S13978405","display_name":"The Medical Journal of Australia","issn_l":"0025-729X","issn":["0025-729X","1326-5377"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Australia","raw_type":"journal-article"},{"id":"pmid:12831383","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12831383","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Medical journal of Australia","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W168236986","https://openalex.org/W1992389336","https://openalex.org/W2036770008","https://openalex.org/W2077091336","https://openalex.org/W2078592976","https://openalex.org/W2099986808","https://openalex.org/W2108403589","https://openalex.org/W2108791771","https://openalex.org/W2109905455","https://openalex.org/W2151279304","https://openalex.org/W2152100136","https://openalex.org/W2159011576","https://openalex.org/W4255396331"],"related_works":["https://openalex.org/W2014511927","https://openalex.org/W2231350932","https://openalex.org/W2037597491","https://openalex.org/W1996158233","https://openalex.org/W1994254530","https://openalex.org/W1520422702","https://openalex.org/W2087280110","https://openalex.org/W2118988525","https://openalex.org/W1976623666"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"outcomes,":[3],"costs":[4,282],"and":[5,16,34,61,79,114,121,133,196,247,302,309],"incremental":[6,273],"cost-effectiveness":[7,274],"of":[8,52,108,199],"heroin":[9,50,115,139,219,298],"detoxification":[10,159,254,296],"performed":[11],"in":[12,17,27,39,111,155,169,197,207,221,255,278,289,291,299,317],"a":[13,28,76,286],"specialist":[14,29,77,300],"clinic":[15,301],"general":[18,37],"practice.":[19],"DESIGN":[20],"AND":[21],"SETTING:":[22],"Randomised":[23],"controlled":[24],"trial":[25],"set":[26],"outpatient":[30],"drug":[31],"treatment":[32,48,171,201,268,312],"centre":[33],"six":[35],"office-based":[36],"practices":[38],"inner":[40],"city":[41],"Sydney,":[42],"Australia.":[43],"PARTICIPANTS:":[44],"115":[45],"people":[46],"seeking":[47],"for":[49,82,85],"dependence,":[51],"whom":[53],"97":[54],"(84%)":[55],"were":[56,69,88,151],"reinterviewed":[57],"at":[58,64,118,233,237,241,269],"Day":[59,65,142,226,242],"8,":[60],"78":[62],"(68%)":[63],"91.":[66,122],"INTERVENTIONS:":[67],"Participants":[68],"randomly":[70],"allocated":[71],"to":[72,125,260,284],"primary":[73,146,162,174,190,256,292,303,318],"care":[74,163,175,191,257,304,319],"or":[75,95,101],"clinic,":[78],"received":[80],"buprenorphine":[81,212],"5":[83],"days":[84],"detoxification,":[86,109],"then":[87],"offered":[89],"either":[90],"maintenance":[91],"therapy":[92],"with":[93,99,136],"methadone":[94],"buprenorphine,":[96],"relapse":[97],"prevention":[98],"naltrexone,":[100],"counselling":[102],"alone.":[103],"MAIN":[104],"OUTCOME":[105],"MEASURES:":[106],"Completion":[107],"engagement":[110],"post-detoxification":[112],"treatment,":[113,127],"use":[116,132,140,183,220],"assessed":[117],"Days":[119],"8":[120,143],"Costs":[123],"relevant":[124],"providing":[126],"including":[128],"staff":[129],"time,":[130],"medication":[131],"diagnostic":[134],"procedures,":[135],"abstinence":[137],"from":[138,297],"on":[141],"as":[144],"the":[145,156,185,222,225,270],"outcome":[147,290],"measure.":[148],"RESULTS:":[149],"There":[150],"no":[152,181],"significant":[153],"differences":[154],"proportions":[157],"completing":[158],"(40/56":[160],"[71%]":[161],"v":[164,176,192],"46/59":[165],"[78%]":[166],"clinic),":[167,179,195],"participating":[168],"postwithdrawal":[170,200,211],"(28/56":[172],"[50%]":[173],"36/59":[177],"[61%]":[178],"reporting":[180],"opiate":[182],"during":[184],"withdrawal":[186],"period":[187],"(13/56":[188],"[23%]":[189],"13/59":[193],"[22%]":[194],"duration":[198],"by":[202,321],"survival":[203],"analysis.":[204],"Most":[205],"participants":[206],"both":[208],"groups":[209],"entered":[210],"maintenance.":[213],"On":[214],"an":[215],"intention-to-treat":[216],"basis,":[217],"self-reported":[218],"month":[223],"before":[224],"91":[227],"interview":[228],"was":[229,258],"significantly":[230],"lower":[231],"than":[232,267],"baseline":[234],"(27":[235],"days/month":[236,240],"baseline,":[238],"14":[239],"91;":[243],"P":[244],"<":[245],"0.001)":[246],"did":[248],"not":[249],"differ":[250],"between":[251],"groups.":[252],"Buprenorphine":[253,311],"estimated":[259],"be":[261,314],"$24":[262],"more":[263],"expensive":[264],"per":[265],"patient":[266],"clinic.":[271],"The":[272],"ratio":[275],"reveals":[276],"that,":[277],"this":[279],"context,":[280],"it":[281],"$20":[283],"achieve":[285],"1%":[287],"improvement":[288],"care.":[293],"CONCLUSIONS:":[294],"Buprenorphine-assisted":[295],"settings":[305,320],"had":[306],"similar":[307],"efficacy":[308],"cost-effectiveness.":[310],"can":[313],"initiated":[315],"safely":[316],"trained":[322],"GPs.":[323]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2102408640","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
